Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

PURPOSE: Response evaluation in patients with glioblastoma after chemoradiotherapy is challenging due to progressive, contrast-enhancing lesions on MRI that do not reflect true tumour progression. In this study, we prospectively evaluated the ability of the PET tracer (18)F-fluorothymidine (FLT), a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Nucl Med Mol Imaging
Asıl Yazarlar: Brahm, Cyrillo G., den Hollander, Martha W., Enting, Roelien H., de Groot, Jan Cees, Solouki, A. Millad, den Dunnen, Wilfred F. A., Heesters, Mart A. A. M., Wagemakers, Michiel, Verheul, Henk M. W., de Vries, Elisabeth G. E., Pruim, Jan, Walenkamp, Annemiek M. E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208814/
https://ncbi.nlm.nih.gov/pubmed/30032322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4090-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller